These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30968244)

  • 21. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study.
    Hoshino J; Nagai K; Kai H; Saito C; Ito Y; Asahi K; Kondo M; Iseki K; Iseki C; Okada H; Kashihara N; Narita I; Wada T; Combe C; Pisoni RL; Robinson BM; Yamagata K
    Clin Exp Nephrol; 2018 Apr; 22(2):309-317. PubMed ID: 28741051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.
    Vichova T; Knot J; Ulman J; Maly M; Motovska Z
    Int Urol Nephrol; 2016 Jul; 48(7):1137-43. PubMed ID: 26995007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression.
    Kataoka H; Ono K; Mochizuki T; Hanafusa N; Imai E; Hishida A; Nitta K
    Kidney Blood Press Res; 2019; 44(3):362-383. PubMed ID: 31203292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
    Kanda E; Usui T; Kashihara N; Iseki C; Iseki K; Nangaku M
    Clin Exp Nephrol; 2018 Apr; 22(2):318-327. PubMed ID: 28884361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
    Atsukawa M; Tsubota A; Toyoda H; Takaguchi K; Kondo C; Okubo T; Hiraoka A; Michitaka K; Fujioka S; Uojima H; Watanabe T; Ikeda H; Asano T; Ishikawa T; Matsumoto Y; Abe H; Kato K; Tsuji K; Ogawa C; Shimada N; Iio E; Mikami S; Tanaka Y; Kumada T; Iwakiri K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):364-369. PubMed ID: 30144366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of anemia and chronic kidney disease on the risk of cardiovascular disease and all-cause mortality among diabetic patients].
    Yang C; Wang JW; Yang YZ; Bai KH; Gao BX; Zhao MH; Zhang LX; Wu SL; Wang F
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):495-500. PubMed ID: 29930419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
    Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
    Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort.
    Ruiz-Quintero M; Redón J; Téllez-Plaza M; Cebrián-Cuenca AM; Navarro-Pérez J; Menéndez E; Perez-Navarro A; Fernández-Giménez A; López-Pineda A; Quesada JA; Pallares-Carratalá V; Gil-Guillen VF; Martin-Moreno JM; Bleda-Cano J; Carrascosa S; Carratalá-Munuera C
    Prim Care Diabetes; 2021 Feb; 15(1):88-94. PubMed ID: 32646765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population--Iwate KENCO Study.
    Ohsawa M; Tanno K; Itai K; Turin TC; Okamura T; Ogawa A; Ogasawara K; Fujioka T; Onoda T; Yoshida Y; Omama S; Ishibashi Y; Nakamura M; Makita S; Tanaka F; Kuribayashi T; Koyama T; Sakata K; Okayama A
    Circ J; 2013; 77(5):1315-25. PubMed ID: 23428718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
    Shen ZW; Xing J; Wang QL; Faheem A; Ji X; Li J; Bian WW; Jiang Z; Li XJ; Xue FZ; Liu J
    Int Urol Nephrol; 2017 Feb; 49(2):303-312. PubMed ID: 27704320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of hospitalization among chronic kidney disease patients in tertiary care hospitals - A single-center experience.
    Salman B; Hussain M; Shafique K; Imtiaz S; Dhrolia MF
    Saudi J Kidney Dis Transpl; 2018; 29(5):1150-1158. PubMed ID: 30381512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study.
    Xie Y; Maziarz M; Tuot DS; Chertow GM; Himmelfarb J; Hall YN
    BMC Nephrol; 2016 Jun; 17(1):57. PubMed ID: 27276913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.